Trial intelligence / Profile preview

TAP-IT: Thoracentesis for Cardiac Pleural Effusion

NCT05017753Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Aug 2021
Primary completion
Mar 2024
Countries
1
01

Overview

Randomised, open-label trial in heart failure (HF) and pleural effusion (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Days alive outside of hospital at 90 days. Started Aug 2021; status: completed.

02

Conditions

heart failure (HF)pleural effusion

Beyond the preview

Go deeper on NCT05017753.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05017753.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call